These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6531397)

  • 21. The investigation of cyclodextrin polymer as a new disintegrant for direct compressed tablets.
    Sekulović D; Zajić L
    Pharmazie; 1987 Aug; 42(8):556. PubMed ID: 3432343
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of drug dissolution rate enhancement from beta-cyclodextrin-drug systems.
    Corrigan OI; Stanley CT
    J Pharm Pharmacol; 1982 Oct; 34(10):621-6. PubMed ID: 6128383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of a sulfamethoxazole-beta-cyclodextrin complex in suppositories].
    Tóth K; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):133-7. PubMed ID: 3739726
    [No Abstract]   [Full Text] [Related]  

  • 24. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
    Gyulai M; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
    [No Abstract]   [Full Text] [Related]  

  • 25. The potential use of cyclodextrins in parenteral formulations.
    Brewster ME; Simpkins JW; Hora MS; Stern WC; Bodor N
    J Parenter Sci Technol; 1989; 43(5):231-40. PubMed ID: 2681643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Benzylisoquinoline alkaloid reactions with barbiturates. Reaction of papaverine with sodium phenobarbital. III. Avoidance of incompatibility by using the beta-cyclodextrin inclusion complex].
    Rácz I; Plachy J; Szabóné Tábori M; Stadlerné Szöke A; Vikmon M; Szejtli J
    Acta Pharm Hung; 1984 Jul; 54(4):154-9. PubMed ID: 6485810
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inclusion compounds of 8 Chinese medicinal volatile oils with beta-cyclodextrin].
    Li SZ; Guan SJ
    Zhong Yao Tong Bao; 1987 Dec; 12(12):27-32, 58-9. PubMed ID: 3446391
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of beta-cyclodextrin on the pharmaceutics of a volatile oil from a Chinese medicine: 2 inclusion methods].
    Li SZ
    Zhong Yao Tong Bao; 1986 Dec; 11(12):31-3. PubMed ID: 2952338
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
    Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
    Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of dipyridamole-beta-cyclodextrin complex in dogs.
    Stracciari GL; Malvisi J; Anfossi P; Fregnan GB
    Arch Int Pharmacodyn Ther; 1989; 300():7-13. PubMed ID: 2619427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of stability and biological effect on cholecalciferol by beta-cyclodextrin complexation.
    Szejtli J; Bolla-Pusztai E; Szabó P; Ferenczy T
    Pharmazie; 1980 Dec; 35(12):779-87. PubMed ID: 6259671
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inactivation of soman by beta-cyclodextrin].
    Saint-André S; Désiré B
    C R Acad Sci III; 1985; 301(3):67-72. PubMed ID: 3930009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing the solubility characteristics of griseofulvin with gamma-cyclodextrin.
    Kata M; Tüske B
    Pharmazie; 1988 Jan; 43(1):52-3. PubMed ID: 3375309
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhancement of pharmacological activity of CERM 3726 with a ground mixture of beta-cyclodextrin in mice.
    Luu SN; Chaperon F; Leinot M; Pourrat A
    Pharm Acta Helv; 1987; 62(12):335-6. PubMed ID: 3441478
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclodextrin encapsulation to prevent the loss of l-menthol and its retention during drying.
    Liu XD; Furuta T; Yoshii H; Linko P; Coumans WJ
    Biosci Biotechnol Biochem; 2000 Aug; 64(8):1608-13. PubMed ID: 10993145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of a complex between the analgesic, 6-benzoyl-benzoxazolidinone (CERM 10194), and beta-cyclodextrin.
    Si-Nang L; Simond J; Schiff V; Trottier D; Pourrat A
    Pharm Acta Helv; 1985; 60(4):112-6. PubMed ID: 4011622
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preparation and investigation of gemfibrozil + dimethyl-beta-cyclodextrin products and solid dosage forms].
    Hassan BH; Aigner Z; Kása P; Hódi K; Eros I
    Acta Pharm Hung; 2005; 75(3):125-32. PubMed ID: 16318236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.